Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Calabretta, B' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 117 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Daheron, L; Zenz, T; Siracusa, LD; Brenner, C; Calabretta, B
      Molecular cloning of Ian4: a BCR/ABL-induced gene that encodes an outer membrane mitochondrial protein with GTP-binding activity

      NUCLEIC ACIDS RESEARCH
    2. Condorelli, F; Salomoni, P; Cotteret, S; Cesi, V; Srinivasula, SM; Alnemri, ES; Calabretta, B
      Caspase cleavage enhances the apoptosis-inducing effects of BAD

      MOLECULAR AND CELLULAR BIOLOGY
    3. Amendola, R; Martinez, R; Negroni, A; Venturelli, D; Tanno, B; Calabretta, B; Raschella, G
      DR-nm23 expression affects neuroblastoma cell differentiation, integrin expression, and adhesion characteristics

      MEDICAL AND PEDIATRIC ONCOLOGY
    4. Powzaniuk, MA; Trotta, R; Loza, MJ; Harth, A; Iozzo, RV; Eisenlohr, LC; Perussia, B; Calabretta, B
      B-Myb overexpression results in activation and increased Fas/Fas ligand-mediated cytotoxicity of T and NK cells

      JOURNAL OF IMMUNOLOGY
    5. Biroccio, A; Benassi, B; D'Agnano, I; D'Angelo, C; Buglioni, S; Mottolese, M; Ricciotti, A; Citro, G; Cosimelli, M; Ramsay, RG; Calabretta, B; Zupi, G
      c-Myb and Bcl-x overexpression predicts poor prognosis in colorectal cancer - Clinical and experimental findings

      AMERICAN JOURNAL OF PATHOLOGY
    6. Negroni, A; Venturelli, D; Tanno, B; Amendola, R; Ransac, S; Cesi, V; Calabretta, B; Raschella, G
      Neuroblastoma specific effects of DR-nm23 and its mutant forms on differentiation and apoptosis

      CELL DEATH AND DIFFERENTIATION
    7. De Falco, G; Bagella, L; Claudio, PP; De Luca, A; Fu, Y; Calabretta, B; Sala, A; Giordano, A
      Physical interaction between CDK9 and B-Myb results in suppression of B-Myb gene autoregulation

      ONCOGENE
    8. Fernandes, MJ; Iscove, NN; Gingras, G; Calabretta, B
      Identification and characterization of the gene for a novel C-type lectin (CLECSF7) that maps near the natural killer gene complex on human chromosome 12

      GENOMICS
    9. Perrotti, D; Iervolino, A; Cesi, V; Cirinna, M; Lombardini, S; Grassilli, E; Bonatti, S; Claudio, PP; Calabretta, B
      BCR-ABL prevents c-Jun-mediated and proteasome-dependent FUS (TLS) proteolysis through a protein kinase C beta II-dependent pathway

      MOLECULAR AND CELLULAR BIOLOGY
    10. Cervellera, M; Raschella, G; Santilli, G; Tanno, B; Ventura, A; Mancini, C; Sevignani, C; Calabretta, B; Sala, A
      Direct transactivation of the anti-apoptotic gene apolipoprotein J (Clusterin) by B-MYB

      JOURNAL OF BIOLOGICAL CHEMISTRY
    11. Venturelli, D; Cesi, V; Ransac, S; Engelhard, A; Perotti, D; Calabretta, B
      The nucleoside diphosphate kinase activity of DRnm23 is not required for inhibition of differentiation and induction of apoptosis in 32Dcl3 myeloid precursor cells

      EXPERIMENTAL CELL RESEARCH
    12. Manzella, L; Gualdi, R; Perrotti, D; Nicolaides, NC; Girlando, G; Giuffrida, MA; Messina, A; Calabretta, B
      The interferon regulatory factors 1 and 2 bind to a segment of the human c-myb first intron: Possible role in the regulation of c-myb expression

      EXPERIMENTAL CELL RESEARCH
    13. Engelhard, A; Campbell, K; Calabretta, B
      B-myb alters the response of myeloid precursor cells to G-CSF

      EXPERIMENTAL CELL RESEARCH
    14. Salomoni, P; Condorelli, F; Sweeney, SM; Calabretta, B
      Versatility of BCR/ABL-expressing leukemic cells in circumventing proapoptotic BAD effects

      BLOOD
    15. Cirinna, M; Trotta, R; Salomoni, P; Kossev, P; Wasik, M; Perrotti, D; Calabretta, B
      Bcl-2 expression restores the leukemogenic potential of a BCR/ABL mutant defective in transformation

      BLOOD
    16. Pagnan, G; Stuart, DD; Pastorino, F; Raffaghello, L; Montaldo, PG; Allen, TM; Calabretta, B; Ponzoni, M
      Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD(2)-targeted immunoliposomes: Antitumor effects

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    17. Putney, SD; Brown, J; Cucco, C; Lee, R; Skorski, T; Leonetti, C; Geiser, T; Calabretta, B; Zupi, G; Zon, G
      Enhanced anti-tumor effects with microencapsulated c-myc antisense oligonucleotide

      ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT
    18. Peruzzi, F; Prisco, M; Dews, M; Salomoni, P; Grassilli, E; Romano, G; Calabretta, B; Baserga, R
      Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis

      MOLECULAR AND CELLULAR BIOLOGY
    19. Iozzo, RV; Chakrani, F; Perrotti, D; McQuillan, DJ; Skorski, T; Calabretta, B; Eichstetter, I
      Cooperative action of germ-line mutations in decorin and p53 accelerates lymphoma tumorigenesis

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    20. Nieborowska-Skorska, M; Wasik, MA; Slupianek, A; Salomoni, P; Kitamura, T; Calabretta, B; Skorski, T
      Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis

      JOURNAL OF EXPERIMENTAL MEDICINE
    21. Sevignani, C; Cranston, A; Iozzo, RV; Fishel, R; Calabretta, B
      Spontaneous and mutagen-induced transformation of primary cultures of Msh2-/-p53-/- colonocytes

      CANCER RESEARCH
    22. Raschella, G; Cesi, V; Amendola, R; Negroni, A; Tanno, B; Altavista, P; Tonini, GP; De Bernardi, B; Calabretta, B
      Expression of B-myb in neuroblastoma tumors is a poor prognostic factor independent from MYCN amplification

      CANCER RESEARCH
    23. Majewski, M; Nieborowska-Skorska, M; Salomoni, P; Slupianek, A; Reiss, K; Trotta, R; Calabretta, B; Skorski, T
      Activation of mitochondrial Raf-1 is involved in the antiapoptotic effectsof Akt

      CANCER RESEARCH
    24. Fernandes, MJ; Finnegan, AA; Siracusa, LD; Brenner, C; Iscove, NN; Calabretta, B
      Characterization of a novel receptor that maps near the natural killer gene complex: Demonstration of carbohydrate binding and expression in hematopoietic cells

      CANCER RESEARCH
    25. Grassilli, E; Salomoni, P; Perrotti, D; Franceschi, C; Calabretta, B
      Resistance to apoptosis in CTLL-2 cells overexpressing B-Myb is associatedwith B-Myb-dependent bcl-2 induction

      CANCER RESEARCH
    26. Calabretta, B; Skorski, T
      Antisense strategies in the treatment of leukemia

      MOLECULAR BASIS OF CELL CYCLE AND GROWTH CONTROL
    27. RASCHELLA G; TANNO B; BONETTO F; NEGRONI A; CLAUDIO PP; BALDI A; AMENDOLA R; CALABRETTA B; GIORDANO A; PAGGI MG
      THE RB-RELATED GENE RB2 P130 IN NEUROBLASTOMA-DIFFERENTIATION AND IN B-MYB PROMOTER DOWN-REGULATION/

      Cell death and differentiation
    28. PERROTTI D; BONATTI S; TROTTA R; MARTINEZ R; SKORSKI T; SALOMONI P; GRASSILLI E; IOZZO RV; COOPER DR; CALABRETTA B
      TLS FUS, A PRO-ONCOGENE INVOLVED IN MULTIPLE CHROMOSOMAL TRANSLOCATIONS, IS A NOVEL REGULATOR OF BCR/ABL-MEDIATED LEUKEMOGENESIS/

      EMBO journal (Print)
    29. SKORSKI T; WLODARSKI P; DAHERON L; SALOMONI P; NIEBOROWSKASKORSKA M; MAJEWSKI M; WASIK M; CALABRETTA B
      BCR ABL-MEDIATED LEUKEMOGENESIS REQUIRES THE ACTIVITY OF THE SMALL GTP-BINDING PROTEIN RAC/

      Proceedings of the National Academy of Sciences of the United Statesof America
    30. SALOMONI P; WASIK MA; RIEDEL RF; REISS K; CHOI JK; SKORSKI T; CALABRETTA B
      EXPRESSION OF CONSTITUTIVELY ACTIVE RAF-1 IN THE MITOCHONDRIA RESTORES ANTIAPOPTOTIC AND LEUKEMOGENIC POTENTIAL OF A TRANSFORMATION-DEFICIENT BCR ABL MUTANT/

      The Journal of experimental medicine
    31. SEVIGNANI C; WLODARSKI P; KIRILLOVA J; MERCER WE; DANIELSON KG; IOZZO RV; CALABRETTA B
      TUMORIGENIC CONVERSION OF P53-DEFICIENT COLON EPITHELIAL-CELLS BY AN ACTIVATED KI-RAS GENE

      The Journal of clinical investigation
    32. CITRO G; DAGNANO I; LEONETTI C; PERINI R; BUCCI B; ZON G; CALABRETTA B; ZUPI G
      C-MYC ANTISENSE OLIGODEOXYNUCLEOTIDES ENHANCE THE EFFICACY OF CISPLATIN IN MELANOMA CHEMOTHERAPY IN-VITRO AND IN NUDE-MICE

      Cancer research
    33. DEFABRITIIS P; PETTI MC; MONTEFUSCO E; DEPROPRIS MS; SALA R; BELLUCCI R; MANCINI M; LISCI A; BONETTO F; GEISER T; CALABRETTA B; MANDELLI F
      BCR-ABL ANTISENSE OLIGODEOXYNUCLEOTIDE IN-VITRO PURGING AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA IN ADVANCED PHASE

      Blood
    34. WLODARSKI P; WASIK M; RATAJCZAK MZ; SEVIGNANI C; HOSER G; KAWIAK J; GEWIRTZ AM; CALABRETTA B; SKORSKI T
      ROLE OF P53 IN HEMATOPOIETIC RECOVERY AFTER CYTOTOXIC TREATMENT

      Blood
    35. RATAJCZAK MZ; PERROTTI D; MELOTTI P; POWZANIUK M; CALABRETTA B; ONODERA K; KREGENOW DA; MACHALINSKI B; GEWIRTZ AM
      MYB AND ETS PROTEINS ARE CANDIDATE REGULATORS OF C-KIT EXPRESSION IN HUMAN HEMATOPOIETIC-CELLS

      Blood
    36. SKORSKI T; NIEBOROWSKASKORSKA M; WLODARSKI P; WASIK M; TROTTA R; KANAKARAJ P; SALOMONI P; ANTONYAK M; MARTINEZ R; MAJEWSKI M; WONG A; PERUSSIA B; CALABRETTA B
      THE SH3 DOMAIN CONTRIBUTES TO BCR ABL-DEPENDENT LEUKEMOGENESIS IN-VIVO - ROLE IN ADHESION, INVASION, AND HOMING/

      Blood
    37. KIRILLOVA J; SEVIGNANI C; WLODARSKI P; CALABRETTA B; MERCER WE
      ESTABLISHMENT AND CHARACTERIZATION OF P53-DEFICIENT MOUSE COLON EPITHELIAL-CELL LINES AND THEIR DERIVATIVES, EXPRESSING MUTANT FORMS OF P53PROTEIN

      Molecular biology of the cell
    38. SANTRA M; MANN DM; MERCER EW; SKORSKI T; CALABRETTA B; IOZZO RV
      ECTOPIC EXPRESSION OF DECORIN PROTEIN CORE CAUSES GENERALIZED GROWTH SUPPRESSION IN NEOPLASTIC-CELLS OF VARIOUS HISTOGENETIC ORIGIN AND REQUIRES ENDOGENOUS P21, AN INHIBITOR OF CYCLIN-DEPENDENT KINASES

      Matrix biology
    39. DEFABRITIIS P; SKORSKI T; DEPROPRIS MS; PAGGI MG; NIEBOROWSKASKORSKA M; LISCI A; BUFFOLINO S; CAMPBELL K; GEISER T; CALABRETTA B
      EFFECT OF BCR-ABL OLIGODEOXYNUCLEOTIDES ON THE CLONOGENIC GROWTH OF CHRONIC MYELOGENOUS LEUKEMIA-CELLS

      Leukemia
    40. CALABRETTA B; SKORSKI T
      TARGETING C-MYC IN LEUKEMIA

      Anti-cancer drug design
    41. SKORSKI T; BELLACOSA A; NIEBOROWSKASKORSKA M; MAJEWSKI M; MARTINEZ R; CHOI JK; TROTTA R; WLODARSKI P; PERROTTI D; CHAN TO; WASIK MA; TSICHLIS PN; CALABRETTA B
      TRANSFORMATION OF HEMATOPOIETIC-CELLS BY BCR ABL REQUIRES ACTIVATION OF A PI-3K/AKT-DEPENDENT PATHWAY/

      EMBO journal
    42. SCARPA S; NEGRONI A; AMENDOLA R; SIGNORELLI P; CALABRETTA B; MODESTI A; RASCHELLA G
      PHENOTYPIC AND MORPHOLOGICAL CHARACTERIZATION OF NEUROBLASTOMA-CELLS CONSTITUTIVELY EXPRESSING B-MYB

      Journal of neuro-oncology
    43. SKORSKI T; PERROTTI D; NIEBOROWSKASKORSKA M; GRYAZNOV S; CALABRETTA B
      ANTILEUKEMIA EFFECT OF C-MYC N3'-]P5' PHOSPHORAMIDATE ANTISENSE OLIGONUCLEOTIDES IN-VIVO

      Proceedings of the National Academy of Sciences of the United Statesof America
    44. DEROCCO SE; IOZZO R; MA XP; SCHWARTING R; PETERSON D; CALABRETTA B
      ECTOPIC EXPRESSION OF A-MYB IN TRANSGENIC MICE CAUSES FOLLICULAR HYPERPLASIA AND ENHANCED B-LYMPHOCYTE PROLIFERATION

      Proceedings of the National Academy of Sciences of the United Statesof America
    45. SALOMONI P; PERROTTI D; MARTINEZ R; FRANCESCHI C; CALABRETTA B
      RESISTANCE TO APOPTOSIS IN CTLL-2 CELLS CONSTITUTIVELY EXPRESSING C-MYB IS ASSOCIATED WITH INDUCTION OF BCL-2 EXPRESSION AND MYB-DEPENDENT REGULATION OF BCL-2 PROMOTER ACTIVITY

      Proceedings of the National Academy of Sciences of the United Statesof America
    46. SALA A; KUNDU M; CASELLA I; ENGELHARD A; CALABRETTA B; GRASSO L; PAGGI MG; GIORDANO A; WATSON RJ; KHALILI K; PESCHLE C
      ACTIVATION OF HUMAN B-MYB BY CYCLINS

      Proceedings of the National Academy of Sciences of the United Statesof America
    47. SANTRA M; MANN DM; MERCER EW; SKORSKI T; CALABRETTA B; IOZZO RV
      ECTOPIC EXPRESSION OF DECORIN PROTEIN CORE CAUSES A GENERALIZED GROWTH SUPPRESSION IN NEOPLASTIC-CELLS OF VARIOUS HISTOGENETIC ORIGIN AND REQUIRES ENDOGENOUS P21, AN INHIBITOR OF CYCLIN-DEPENDENT KINASES

      The Journal of clinical investigation
    48. MARTINEZ R; VENTURELLI D; PERROTTI D; VERONESE ML; KASTURY K; DRUCK T; HUEBNER K; CALABRETTA B
      GENE STRUCTURE, PROMOTER ACTIVITY, AND CHROMOSOMAL LOCATION OF THE DR-NM23 GENE, A RELATED MEMBER OF THE NM23 GENE FAMILY

      Cancer research
    49. BELLON T; PERROTTI D; CALABRETTA B
      GRANULOCYTIC DIFFERENTIATION OF NORMAL HEMATOPOIETIC PRECURSOR CELLS INDUCED BY TRANSCRIPTION FACTOR PU.1 CORRELATES WITH NEGATIVE REGULATION OF THE C-MYB PROMOTER

      Blood
    50. PERROTTI D; MARTINEZ R; TROTTA R; SALOMONI P; SKORSKI T; CALABRETTA B
      REGULATION OF BCR ABL LEUKEMIC PHENOTYPE - ROLE OF A 68 KDA RNA-BINDING PROTEIN/

      Blood
    51. NIEBOROWSKASKORSKA M; BELLACOSA A; MARTINEZ R; MAJEWSKI M; CHOI JK; TROTTA R; WLODARSKI P; PERROTTI D; CHAN TO; WASIK MA; TSICHLIS PN; CALABRETTA B; SKORSKI T
      TRANSFORMATION OF HEMATOPOIETIC-CELLS BY BCR ABL REQUIRES ACTIVATION OF A PI-3K/AKT-DEPENDENT PATHWAY/

      Blood
    52. WLODARSKI P; WASIK M; RATAJCZAK MZ; SEVIGNANI C; HOSER G; KAWIAK I; GEWIRTZ AM; CALABRETTA B; SKORSKI T
      ROLE OF P53 IN HEMATOPOIETIC RECOVERY AFTER CYTOSTATIC TREATMENT

      Blood
    53. SORIO C; MELOTTI P; DARCANGELO D; MENDROLA J; CALABRETTA B; CROCE CM; HUEBNER K
      RECEPTOR PROTEIN-TYROSINE-PHOSPHATASE-GAMMA, PTP-GAMMA, REGULATES HEMATOPOIETIC DIFFERENTIATION

      Blood
    54. SKORSKI T; NIEBOROWSKASKORSKA M; WLODARSKI P; PERROTTI D; HOSER G; KAWIAK J; MAJEWSKI M; CHRISTENSEN L; IOZZO RV; CALABRETTA B
      TREATMENT OF PHILADELPHIA LEUKEMIA IN SEVERE COMBINED IMMUNODEFICIENTMICE BY COMBINATION OF CYCLOPHOSPHAMIDE AND BCR ABL ANTISENSE OLIGODEOXYNUCLEOTIDES/

      Journal of the National Cancer Institute
    55. AMENDOLA R; MARTINEZ R; NEGRONI A; VENTURELLI D; TANNO B; CALABRETTA B; RASCHELLA G
      DR-NM23 GENE-EXPRESSION IN NEUROBLASTOMA-CELLS - RELATIONSHIP TO INTEGRIN EXPRESSION, ADHESION CHARACTERISTICS, AND DIFFERENTIATION

      Journal of the National Cancer Institute
    56. AMENDOLA R; NEGRONI A; MARTINEZ R; TONINI G; VENTURELLI D; CALABRETTA B; RASCHELLA G
      ROLE OF DR-NM23 IN NEUROBLASTOMA CELL-DIFFERENTIATION AND ITS EXPRESSION IN TUMOR

      Molecular biology of the cell
    57. MARTINEZ R; VENTURELLI D; PERROTTI D; VERONESE ML; KASTURY K; DRUCK T; HUEBNER K; CALABRETTA B
      GENE STRUCTURE, PROMOTER ACTIVITY AND CHROMOSOMAL LOCATION OF THE DR-NM23 GENE

      Molecular biology of the cell
    58. PERROTTI D; BELLON T; TROTTA R; MARTINEZ R; CALABRETTA B
      A CELL PROLIFERATION-DEPENDENT MULTIPROTEIN COMPLEX NC-3A POSITIVELY REGULATES THE CD34 PROMOTER VIA ATCATTT-CONTAINING ELEMENT

      Molecular biology of the cell
    59. CALABRETTA B; SKORSKI T
      BCR ABL REGULATION OF PI-3 KINASE-ACTIVITY

      Leukemia & lymphoma
    60. MELOTTI CSP; DARCANGELO D; MENDROLA J; CALABRETTA B; CROCE CM; HUEBNER K
      RECEPTOR PROTEIN-TYROSINE-PHOSPHATASE-GAMMA REGULATES HEMATOPOIETIC DIFFERENTIATION

      Journal of leukocyte biology
    61. GRYAZNOV S; SKORSKI T; CUCCO C; NIEBOROWSKASKORSKA M; CHIU CY; LLOYD D; CHEN JK; KOZIOLKIEWICZ M; CALABRETTA B
      OLIGONUCLEOTIDE N3'-]P5' PHOSPHORAMIDATES AS ANTISENSE AGENTS

      Nucleic acids research
    62. CALABRETTA B; SKORSKI T; RATAJCZAK MZ; GEWIRTZ AM
      ANTISENSE STRATEGIES IN THE TREATMENT OF LEUKEMIAS

      Seminars in oncology
    63. SKORSKI T; NIEBOROWSKASKORSKA M; WLODARSKI P; PERROTTI D; MARTINEZ R; WASIK MA; CALABRETTA B
      BLASTIC TRANSFORMATION OF P53-DEFICIENT BONE-MARROW CELLS BY P210(BCRABL) TYROSINE KINASE/

      Proceedings of the National Academy of Sciences of the United Statesof America
    64. MELOTTI P; CALABRETTA B
      THE TRANSCRIPTION FACTORS C-MYB AND GATA-2 ACT INDEPENDENTLY IN THE REGULATION OF NORMAL HEMATOPOIESIS

      Proceedings of the National Academy of Sciences of the United Statesof America
    65. SALA A; CASELLA I; BELLON T; CALABRETTA B; WATSON RJ; PESCHLE C
      B-MYB PROMOTES S-PHASE AND IS A DOWNSTREAM TARGET OF THE NEGATIVE REGULATOR P107 IN HUMAN-CELLS

      The Journal of biological chemistry
    66. RASCHELLA G; NEGRONI A; PUCCI S; AMENDOLA R; VALERI S; CALABRETTA B
      B-MYB TRANSCRIPTIONAL REGULATION AND MESSENGER-RNA STABILITY DURING DIFFERENTIATION OF NEUROBLASTOMA-CELLS

      Experimental cell research
    67. FIDANZA V; MELOTTI P; YANO T; NAKAMURA T; BRADLEY A; CANAANI E; CALABRETTA B; CROCE CM
      DOUBLE KNOCKOUT OF THE ALL-1 GENE BLOCKS HEMATOPOIETIC DIFFERENTIATION IN-VITRO

      Cancer research
    68. CUCCO C; CALABRETTA B
      IN-VITRO AND IN-VIVO REVERSAL OF MULTIDRUG-RESISTANCE IN A HUMAN LEUKEMIA-RESISTANT CELL-LINE BY MDR1 ANTISENSE OLIGODEOXYNUCLEOTIDES

      Cancer research
    69. RATAJCZAK MZ; RATAJCZAK J; SKORSKA M; MARLICZ W; CALABRETTA B; PLETCHER CH; MOORE J; GEWIRTZ AM
      EFFECT OF BASIC (FGF-2) AND ACIDIC (FGF-1) FIBROBLAST GROWTH-FACTORS ON EARLY HEMATOPOIETIC-CELL DEVELOPMENT

      British Journal of Haematology
    70. DELBUFALO D; CUCCO C; LEONETTI C; CITRO G; DAGNANO I; BENASSI M; GEISER T; ZON G; CALABRETTA B; ZUPI G
      EFFECT OF CISPLATIN AND C-MYB ANTISENSE PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES COMBINATION ON A HUMAN COLON-CARCINOMA CELL-LINE IN-VITRO AND IN-VIVO

      British Journal of Cancer
    71. PERROTTI D; BELLON T; TROTTA R; MARTINEZ R; CALABRETTA B
      A CELL PROLIFERATION-DEPENDENT MULTIPROTEIN COMPLEX NC-3A POSITIVELY REGULATES THE CD34 PROMOTER VIA A TCATTT-COUTAINING ELEMENT

      Blood
    72. SKORSKI T; NIEBOROWSKASKORSKA M; WLODARSKI P; ZON G; IOZZO RV; CALABRETTA B
      ANTISENSE OLIGODEOXYNUCLEOTIDE COMBINATION THERAPY OF PRIMARY CHRONICMYELOGENOUS LEUKEMIA BLAST CRISIS IN SCID MICE

      Blood
    73. NIEBOROWSKASKORSKA M; WLODARSKI P; PERROTTI D; MARTINEZ R; WASIK MA; CALABRETTA B; SKORSKI T
      BCR ABL INDUCES ELASTIC TRANSFORMATION OF P53-DEFICIENT BONE-MARROW CELLS/

      Blood
    74. SKORSKI T; NIEBOROWSKASKORSKA M; WLODARSKI P; WASIK M; TROTTA R; KANAKARAJ P; SALOMONI P; ANTONYAK M; MARTINEZ R; MAJEWSKI M; WONG A; PERUSSIA B; CALABRETTA B
      AN INTACT SH3 DOMAIN IS REQUIRED FOR BCR ABL LEUKEMOGENESIS IN-VIVO -ROLE IN ADHESION, INVASION AND HOMING/

      Blood
    75. NIEBOROWSKASKORSKA M; WLODARSKI P; PERROTTI D; HOSER G; KAWIAK J; MAJEWSKI M; IOZZO RV; CALABRETTA B; SKORSKI T
      TREATMENT OF PHILADELPHIA(1) LEUKEMIA IN SCID MICE BY COMBINATION OF CYCLOPHOSPHAMIDE AND BCR ABL ANTISENSE OLIGODEOXYNUCLEOTIDES/

      Blood
    76. MELOTTI P; CALABRETTA B
      INDUCTION OF HEMATOPOIETIC COMMITMENT AND ERYTHROMYELOID DIFFERENTIATION IN EMBRYONAL STEM-CELLS CONSTITUTIVELY EXPRESSING C-MYB

      Blood
    77. LEONETTI C; DAGNANO I; LOZUPONE F; VALENTINI A; GEISER T; ZON G; CALABRETTA B; CITRO G; ZUPI G
      ANTITUMOR EFFECT OF C-MYC ANTISENSE PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES ON HUMAN-MELANOMA CELLS IN-VITRO AND IN MICE

      Journal of the National Cancer Institute
    78. DEFABRITIIS P; AMADORI S; PETTI MC; MANCINI M; MONTEFUSCO E; PICARDI A; GEISER T; CAMPBELL K; CALABRETTA B; MANDELLI F
      IN-VITRO PURGING WITH BCR-ABL ANTISENSE OLIGODEOXYNUCLEOTIDES DOES NOT PREVENT HEMATOLOGIC RECONSTITUTION AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION

      Leukemia
    79. DEFABRITIIS P; CALABRETTA B
      ANTISENSE OLIGODEOXYNUCLEOTIDES FOR THE TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA - ARE THEY STILL A PROMISE

      Haematologica
    80. PERROTTI D; MELOTTI P; SKORSKI T; CASELLA I; PESCHLE C; CALABRETTA B
      OVEREXPRESSION OF THE ZINC-FINGER PROTEIN MZF1 INHIBITS HEMATOPOIETICDEVELOPMENT FROM EMBRYONIC STEM-CELLS - CORRELATION WITH NEGATIVE REGULATION OF CD34 AND C-MYB PROMOTER ACTIVITY

      Molecular and cellular biology
    81. VENTURELLI D; MARTINEZ R; MELOTTI P; CASELLA I; PESCHLE C; CUCCO C; SPAMPINATO G; DARZYNKIEWICZ Z; CALABRETTA B
      OVEREXPRESSION OF DR-NM23, A PROTEIN ENCODED BY A MEMBER OF THE NM23 GENE FAMILY, INHIBITS GRANULOCYTE DIFFERENTIATION AND INDUCES APOPTOSIS IN 32DC13 MYELOID CELLS

      Proceedings of the National Academy of Sciences of the United Statesof America
    82. SANTRA M; SKORSKI T; CALABRETTA B; LATTIME EC; IOZZO RV
      DE-NOVO DECORIN GENE-EXPRESSION SUPPRESSES THE MALIGNANT PHENOTYPE INHUMAN COLON-CANCER CELLS

      Proceedings of the National Academy of Sciences of the United Statesof America
    83. AZZONI L; ANEGON I; CALABRETTA B; PERUSSIA B
      LIGAND-BINDING TO FC-GAMMA-R INDUCES C-MYC-DEPENDENT APOPTOSIS IN IL-2-STIMULATED NK CELLS

      The Journal of immunology
    84. SKORSKI T; NIEBOROWSKASKORSKA M; CAMPBELL K; IOZZO RV; ZON G; DARZYNKIEWICZ Z; CALABRETTA B
      LEUKEMIA TREATMENT IN SEVERE COMBINED IMMUNODEFICIENCY MICE BY ANTISENSE OLIGODEOXYNUCLEOTIDES TARGETING COOPERATING ONCOGENES

      The Journal of experimental medicine
    85. RASCHELLA G; NEGRONI A; SALA A; PUCCI S; ROMEO A; CALABRETTA B
      REQUIREMENT OF B-MYB FUNCTION FOR SURVIVAL AND DIFFERENTIATIVE POTENTIAL OF HUMAN NEUROBLASTOMA-CELLS

      The Journal of biological chemistry
    86. WEN SC; KU DH; DELUCA A; CLAUDIO PP; GIORDANO A; CALABRETTA B
      ETS-2 REGULATES CDC2 KINASE-ACTIVITY IN MAMMALIAN-CELLS - COORDINATEDEXPRESSION OF CDC2 AND CYCLIN-A

      Experimental cell research
    87. SKORSKI T; NIEBOROWSKASKORSKA M; SZCZYLIK C; KANAKARAJ P; PEROTTI D; ZON G; GEWIRTZ A; PERUSSIA B; CALABRETTA B
      C-RAF-1 SERINE THREONINE KINASE IS REQUIRED IN BCR ABL-DEPENDENT AND NORMAL HEMATOPOIESIS/

      Cancer research
    88. SALA A; BELLON T; MELOTTI P; PESCHLE C; CALABRETTA B
      INHIBITION OF ERYTHRO-MYELOID DIFFERENTIATION BY CONSTITUTIVE EXPRESSION OF A DNA BINDING-DEFICIENT C-MYB MUTANT - IMPLICATION FOR C-MYB FUNCTION

      Blood
    89. SKORSKI T; KANAKARAJ P; NIEBOROWSKASKORSKA M; RATAJCZAK MZ; WEN SC; ZON G; GEWIRTZ AM; PERUSSIA B; CALABRETTA B
      PHOSPHATIDYLINOSITOL-3 KINASE-ACTIVITY IS REGULATED BY BCR ABL AND ISREQUIRED FOR THE GROWTH OF PHILADELPHIA-CHROMOSOME-POSITIVE CELLS/

      Blood
    90. SKORSKI T; NIEBOROWSKASKORSKA M; WLODARSKI P; CALABRETTA B
      HUMAN LEUKEMIA TREATMENT IN SCID MICE BY ANTISENSE - OLIGODEOXYNUCLEOTIDES TARGETING COOPERATING ONCOGENES

      Blood
    91. SKORSKI T; NIEBOROWSKASKORSKA M; WLODARSKI P; CALABRETTA B
      SYNERGISTIC ANTILEUKEMIA EFFECT OF 2 APOPTOSIS-INDUCING AGENTS - MAFOSFAMIDE AND BCR ABL ANTISENSE OLIGODEOXYNUCLEOTIDES/

      Blood
    92. LANGE B; GEWIRTZ A; CALABRETTA B
      SCREENING FOR EARLY DOWN-REGULATION OF C-MYC AND C-MYB MESSENGER-RNA IN PEDIATRIC ACUTE MYELOID-LEUKEMIA (AML)

      Blood
    93. SMETSERS TFCM; SKORSKI T; VANDELOCHT LTF; WESSELS HMC; PENNINGS AHM; DEWITTE T; CALABRETTA B; MENSINK EJBM
      ANTISENSE BCR-ABL OLIGONUCLEOTIDES INDUCE APOPTOSIS IN THE PHILADELPHIA-CHROMOSOME-POSITIVE CELL-LINE BV173

      Leukemia
    94. NIEBOROWSKASKORSKA M; RATAJCZAK MZ; CALABRETTA B; SKORSKI T
      THE ROLE OF C-MYC PROTOONCOGENE IN CHRONIC MYELOGENOUS LEUKEMIA

      Folia histochemica et cytobiologica
    95. NIEBOROWSKASKORSKA M; NAKASHIMA M; RATAJCZAK M; STEPLEWSKI Z; CALABRETTA B; SKORSKI T
      ONCOGENE-TARGETED ANTISENSE OLIGODEOXYNUCLEOTIDES COMBINED WITH CHEMOTHERAPY OR IMMUNOTHERAPY - A NEW APPROACH FOR TUMOR TREATMENT

      Folia histochemica et cytobiologica
    96. SKORSKI T; NIEBOROWSKASKORSKA M; NICOLAIDES NC; SZCZYLIK C; IVERSEN P; IOZZO RV; ZON G; CALABRETTA B
      SUPPRESSION OF PHILADELPHIA(1) LEUKEMIA-CELL GROWTH IN MICE BY BCR-ABL ANTISENSE OLIGODEOXYNUCLEOTIDE

      Proceedings of the National Academy of Sciences of the United Statesof America
    97. SKORSKI T; KANAKARAJ P; KU DH; NIEBOROWSKASKORSKA M; CANAANI E; ZON G; PERUSSIA B; CALABRETTA B
      NEGATIVE REGULATION OF P120GAP GTPASE PROMOTING ACTIVITY BY P2L0(BCR ABL) - IMPLICATION FOR RAS-DEPENDENT PHILADELPHIA-CHROMOSOME-POSITIVE CELL-GROWTH/

      The Journal of experimental medicine
    98. MELOTTI P; KU DH; CALABRETTA B
      REGULATION OF THE EXPRESSION OF THE HEMATOPOIETIC STEM-CELL ANTIGEN CD34 - ROLE OF C-MYB

      The Journal of experimental medicine
    99. MELOTTI P; CALABRETTA B
      ETS-2 AND C-MYB ACT INDEPENDENTLY IN REGULATING EXPRESSION OF THE HEMATOPOIETIC STEM-CELL ANTIGEN CD34

      The Journal of biological chemistry
    100. RASCHELLA G; ROMEO A; NEGRONI A; PUCCI S; DOMINICI C; CASTELLO MA; BEVILACQUA P; FELSANI A; CALABRETTA B
      LACK OF CORRELATION BETWEEN N-MYC AND MAX EXPRESSION IN NEUROBLASTOMATUMORS AND IN CELL-LINES - IMPLICATION FOR N-MYC-MAX COMPLEX-FORMATION

      Cancer research


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 30/10/20 alle ore 20:25:06